Stay updated with breaking news from Keith Pinder. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Q BioMed Inc. (OTCQB: QBIO), a commercial stage biotech company, announced today that it has recently entered into an exclusive distribution...
Q BioMed Engages Contract Sales Force with Deep VA and Oncology Experience Company Expands Strontium89 Reach Through Partnership with WSI, a Federally Focused Contract Sales Organization News provided by Share this article NEW YORK, May 20, 2021 /PRNewswire/ -- Q BioMed Inc. (OTCQB: QBIO), a commercial stage biotech company, announced today that it has hired WSI PBG, LLC (WSI), a Michigan based firm specializing in creating access for and selling pharmaceuticals, medical diagnostics and durable medical equipment in the Veterans Administration (VA), Military Health System (MHS) and Indian H...
Q BioMed Insider to Invest up to $30M in the Company Aedesius Holdings Ltd. (AedesiusOne), a privately held global disruption aggregator, enters Into $30M Securities Purchase Agreement with Q BioMed Up front investment of up to $20M with an optional $10M in 6 month warrants Proceeds may be used for deploying contract sales force, advancing pipeline, redeeming outstanding convertible debt and convertible preferred shares and acquiring later-stage asset(s) News provided by Share this article QBIO), announced today that it has signed a securities purchase agreement ("Transaction") with Aedesius ...
Q BioMed Updates Shareholders Technology partner, Mannin Research, receives new R&D funding for COVID project and Several Milestones Expected in 2021 News provided by Share this article Share this article NEW YORK, April 27, 2021 /PRNewswire/ -- Q BioMed Inc. (OTCQB: QBIO), a commercial stage biotech company, updates shareholders. In March 2021,it was announced that our technology partner, Mannin Research Inc. (Mannin), is receiving up to CAD$1.7 million in research and development funding from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP) to supp...
Predictive Oncology Announces $7.4 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules February 11, 2021 00:30 ET | Source: Predictive Oncology Inc. Predictive Oncology Inc. Eagan, Minnesota, UNITED STATES MINNEAPOLIS, Feb. 10, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology” or “the Company”), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, today announced that it has entered into definitive agreemen...